« Return to News | CROs/Service Providers

ClinicalRM awarded USAMMDA contract

Friday, November 16, 2012 12:00 PM

Clinical Research Management, a full-service CRO based in Hinckley, Ohio, has been awarded a U.S. Army Medical Materiel Development Activity (USAMMDA) contract. 

ClinicalRM will provide regulatory support personnel and may also provide equipment, supplies, facilities, transportations, tools and materials necessary to support USAMMDA's mission.  The contract is effective for 5 years, including option renewals, as of November 1, 2012.

USAMMDA supports ongoing efforts to develop new drugs, vaccines, devices and medical support equipment that enhance readiness, endures the provision of the highest quality medical care to the Department of Defense, and maximizes the survival of medical casualties on the battlefield.

"ClinicalRM is honored to continue the support of the important USAMMDA mission through this new contract," said Edie Druktenis, program manager, ClinicalRM. "Our staff is highly qualified and have proven to be a great asset to the mission over the last couple of years to move solutions forward, developing medical material to protect and sustain the warfighter.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.